PubRank

Harry Rakowski

Author PubWeight™ 97.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003 11.88
2 Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002 3.71
3 2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2011 3.57
4 ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003 3.42
5 Results of surgery for aortic root aneurysm in patients with Marfan syndrome. J Thorac Cardiovasc Surg 2003 3.17
6 Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009 3.00
7 ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation 2003 2.97
8 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011 2.90
9 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011 2.53
10 American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008 2.25
11 Severe multivalvular heart disease: a new complication of the ergot derivative dopamine agonists. Mov Disord 2004 2.19
12 ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol 2003 2.02
13 Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice. JACC Cardiovasc Imaging 2009 1.94
14 Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 2005 1.83
15 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011 1.70
16 Hand-carried cardiac ultrasound (HCU) device: recommendations regarding new technology. A report from the Echocardiography Task Force on New Technology of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002 1.69
17 Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR. JACC Cardiovasc Imaging 2013 1.69
18 Late outcomes of mitral valve repair for floppy valves: Implications for asymptomatic patients. J Thorac Cardiovasc Surg 2003 1.69
19 Long-term survival in patients with resting obstructive hypertrophic cardiomyopathy comparison of conservative versus invasive treatment. J Am Coll Cardiol 2011 1.65
20 A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. J Thorac Cardiovasc Surg 2005 1.61
21 Left ventricular strain patterns in dilated cardiomyopathy predict response to cardiac resynchronization therapy: timing is not everything. J Am Soc Echocardiogr 2009 1.61
22 Adverse left ventricular mechanics in adults with repaired tetralogy of Fallot. Am J Cardiol 2008 1.61
23 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg 2011 1.59
24 Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. JACC Cardiovasc Interv 2011 1.40
25 A diagnostic odyssey: detection of an unusual anterior papillary muscle of the tricuspid valve. Eur J Echocardiogr 2010 1.39
26 Intraoperative transesophageal echocardiography accurately predicts mitral valve anatomy and suitability for repair. J Am Soc Echocardiogr 2002 1.27
27 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011 1.27
28 Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 2008 1.24
29 Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2011 1.06
30 Enlarged left atrial volume in hypertrophic cardiomyopathy: a marker for disease severity. J Am Soc Echocardiogr 2005 1.02
31 Repeated and targeted transfer of angiogenic plasmids into the infarcted rat heart via ultrasound targeted microbubble destruction enhances cardiac repair. Eur Heart J 2010 1.00
32 Surgical management of valvular heart disease 2004. Can J Cardiol 2004 0.99
33 Late hemodynamic and clinical outcomes of aortic valve replacement with the Carpentier-Edwards Perimount pericardial bioprosthesis. J Thorac Cardiovasc Surg 2002 0.98
34 Comparison of two different speckle tracking software systems: does the method matter? Echocardiography 2011 0.96
35 Diastolic myocardial mechanics in hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2010 0.94
36 Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J 2009 0.94
37 Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg 2005 0.93
38 Toronto hypertrophic cardiomyopathy genotype score for prediction of a positive genotype in hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2012 0.93
39 Determination of left ventricular ejection fraction using intravenous contrast and a semiautomated border detection algorithm. J Am Soc Echocardiogr 2003 0.92
40 Relation of myocardial mechanics in severe aortic stenosis to left ventricular ejection fraction and response to aortic valve replacement. Am J Cardiol 2011 0.92
41 Epiaortic scanning modifies planned intraoperative surgical management but not cerebral embolic load during coronary artery bypass surgery. Anesth Analg 2008 0.92
42 Deep basal inferoseptal crypts occur more commonly in patients with hypertrophic cardiomyopathy due to disease-causing myofilament mutations. Radiology 2013 0.92
43 Mitral annular disjunction in advanced myxomatous mitral valve disease: echocardiographic detection and surgical correction. J Am Soc Echocardiogr 2005 0.90
44 Velocity vector imaging in the measurement of left ventricular myocardial mechanics on cardiac magnetic resonance imaging: correlations with echocardiographically derived strain values. J Am Soc Echocardiogr 2013 0.90
45 W4R variant in CSRP3 encoding muscle LIM protein in a patient with hypertrophic cardiomyopathy. Mol Genet Metab 2005 0.89
46 The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. Biomaterials 2012 0.86
47 Low Operative Mortality Achieved With Surgical Septal Myectomy: Role of Dedicated Hypertrophic Cardiomyopathy Centers in the Management of Dynamic Subaortic Obstruction. J Am Coll Cardiol 2015 0.85
48 Hypertrophy pattern and regional myocardial mechanics are related in septal and apical hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2010 0.85
49 Effect of pregnancy on left ventricular motion (twist) in women with aortic stenosis. Am J Cardiol 2008 0.84
50 Quantification of mitral valve anatomy by three-dimensional transesophageal echocardiography in mitral valve prolapse predicts surgical anatomy and the complexity of mitral valve repair. J Am Soc Echocardiogr 2012 0.83
51 Impact of frequent nocturnal hemodialysis on myocardial mechanics and cardiomyocyte gene expression. Circ Cardiovasc Imaging 2012 0.83
52 Quantifying diastolic function in hypertrophic cardiomyopathy: the ongoing search for the holy grail. Circulation 2007 0.81
53 Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2013 0.81
54 Evaluation of left ventricular relaxation and filling pressures in obstructive hypertrophic cardiomyopathy: comparison between invasive hemodynamics and two-dimensional speckle tracking. Echocardiography 2012 0.81
55 Assessment of mitral valve prolapse by 3D TEE angled views are key. JACC Cardiovasc Imaging 2011 0.79
56 Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy. Echocardiography 2012 0.78
57 The role of echocardiography in hypertrophic cardiomyopathy. Curr Cardiol Rep 2015 0.78
58 Subaortic right ventricular characteristics and relationship to exercise capacity in congenitally corrected transposition of the great arteries. J Am Soc Echocardiogr 2012 0.78
59 Determinants of implantable defibrillator discharges in high-risk patients with hypertrophic cardiomyopathy. Heart 2007 0.78
60 Surgical myectomy for hypertrophic obstructive cardiomyopathy: the cut that heals. Circulation 2013 0.78
61 Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you. J Am Soc Echocardiogr 2008 0.77
62 Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol 2004 0.77
63 Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre. Can J Cardiol 2003 0.77
64 Velocity Vector Imaging: standard tissue-tracking results acquired in normals--the VVI-STRAIN study. J Am Soc Echocardiogr 2012 0.76
65 Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: do we need to stand to be counted. J Am Soc Echocardiogr 2011 0.76
66 Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation. J Invasive Cardiol 2004 0.76
67 Mitral valve repair and annular motion: is less really more? J Am Soc Echocardiogr 2011 0.75
68 Diastolic dysfunction and histopathology in hypertrophic cardiomyopathy: is relaxation in disarray? J Am Soc Echocardiogr 2009 0.75
69 Predicting the future in hypertrophic cardiomyopathy: from histopathology to flow to function. J Am Soc Echocardiogr 2012 0.75
70 Physiologic or pathologic hypertrophy: how can we know? Expert Rev Cardiovasc Ther 2014 0.75
71 Myocardial mechanics explains the time course of benefit for septal ethanol ablation for hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2007 0.75
72 Meeting highlights of the 14th annual scientific sessions of the American Society of Echocardiography: June 11 to 14, 2003, in Las Vegas, Nevada. J Am Coll Cardiol 2003 0.75
73 Does myectomy convey survival benefit in hypertrophic cardiomyopathy? Heart Fail Clin 2007 0.75
74 Myocardial contrast echocardiography in chronic ischemic and nonischemic cardiomyopathies. Cardiol Clin 2004 0.75
75 Cardiac magnetic resonance imaging findings predict major adverse events in apical hypertrophic cardiomyopathy. J Thorac Imaging 2014 0.75
76 Imaging highlights from the 2008 Scientific Session of the American College of Cardiology. JACC Cardiovasc Imaging 2008 0.75
77 Dr. Douglas E. Wigle. Am J Cardiol 2015 0.75